[Quetiapine, an antipsychotic agent to consider in the differential diagnosis of convulsions].
M P
MP
Rodrigo Casanova
S
S
Castrillo Villamando
J M
JM
García Peña
L
L
Aguilera Celorrio
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D001569:Benzodiazepines / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D003244:Consciousness Disorders / Q000139:chemically induced; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D004359:Drug Therapy, Combination; D004630:Emergencies; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D000069348:Quetiapine Fumarate; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology; D011968:Receptors, Histamine / Q000187:drug effects / Q000502:physiology
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D011942:Receptors, Adrenergic, alpha; D011968:Receptors, Histamine; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D000077152:Olanzapine